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ABSTRACT:
As an integrated system, hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) is able to provide simultaneously complementary high-resolution anatomic, molecular and functional information, allowing comprehensive cancer phenotyping in a single imaging examination. In addition to an improved patient experience by combining two separate imaging examinations and streamlining the patient pathway, the superior soft tissue contrast resolution of MRI and the ability to acquire multi-parametric MRI data is advantageous over computed tomography (CT). For gastrointestinal cancers this will improve tumor staging, assessment of neoadjuvant response and of the likelihood of a complete (R0) resection in comparison to PET/CT.
BODY:
The number of installed hybrid positron emission tomography/magnetic resonance imaging (PET/MRI) scanners has increased steadily since their clinical introduction in 2010. Current scanners combine a PET system with a 3-tesla (3T) MRI, either as an integrated or sequential system [1, 2] . In an integrated system, PET and MRI are co-located with the PET detectors embedded within the MRI system. In a sequential scanner, the MRI and PET are linked with a shuttle system, allowing the patient to be transferred directly from one system to another yet maintaining the same patient table position to facilitate co-registration of PET and MRI ( Table 1) .
Integration of PET with MRI has been challenging but eventually achieved through substantial engineering advances [3] . The MRI static B0 and radiofrequency B1 magnetic field and radiofrequency pulse will affect electron paths, cause heating, vibration and interference with PET electronics. Likewise, PET components may affect the homogeneity of the MRI B0 field and radiofrequency detection. Integration has required the replacement of standard PET photomultiplier tubes with magnetic field-insensitive avalanche photodiodes or silicon photomultipliers; incorporation of additional shielding around the PET system and redesign of electronics [3] . MRI radiofrequency surface coils also have been designed to be 'PET transparent' with minimal attenuation of emitted photons.
Integration has brought new challenges for PET attenuation correction, an essential part of PET imaging [4] . PET radionuclide decay results in the emission of two opposing 511 keV annihilation photons. Some photons are attenuated or scattered by body tissues before being detected causing signal loss proportional to the distance from the surface and regional tissue density. Non-attenuation-corrected PET data will generally underestimate tracer activity deep within the body. With a hybrid PET/computed tomography (CT) system, attenuation correction using CT based X-ray attenuation, scaled to reflect the attenuation of higher energy 511keV emission photons, enables accurate quantification [5] .
With hybrid PET/MRI this is not possible, as MRI signal intensity is not based on tissue density as with CT but on proton density and relaxation properties, requiring alternative methods [4] . In current systems, dedicated attenuation correction sequences may be acquired, most commonly a 2-point Dixon 3D gradient echo, deriving an attenuation map (µ map) based on four tissue types: background air, lungs, soft-tissue, and fat. A limitation of such methodology is the classification of bone as soft-tissue, which may lead to standardized uptake value (SUV) underestimations of bone lesions by as much as 30% [6] [7] [8] .
Ongoing work on ultra-short time-to-echo (TE) MRI sequences may improve bone classification at the expense of a longer acquisition time and possible artefacts with large field-of-view imaging (which is the norm for whole body imaging) [9] . Alternatives, including atlas-based methods and software-based artificial intelligence algorithms (e.g. neural networks and fuzzy logic) to segment anatomical structures such as soft tissue and bone for attenuation correction, are also under consideration [10] .
Another issue for attenuation correction is that the MRI field-of-view is smaller than the PET field-of-view. This can affect MR attenuation correction if anatomical structures lie outside the field-of-view, e.g. in obese patients. The arms may also be truncated by the MRI field-ofview. A current workaround in clinical systems is to iteratively extract the contours of the arms from PET data (maximum likelihood reconstruction of attenuation and activity [11]) and to use this information to complete the MR based attenuation correction map of the body.
Currently, hybrid PET/MRI is evolving from being just a research tool to include clinical applications, as the high sensitivity of PET acts synergistically with the high contrast and spatial resolution of MRI. It is also possible to include locoregional MRI functional sequences, including diffusion weighted MRI, dynamic contrast enhanced MRI and blood oxygenation level dependent MRI to provide a more comprehensive evaluation of underlying tumor biology and physiology. This is particularly promising for imaging gastrointestinal cancers.
Nevertheless, a 3T MRI system does bring some challenges for body imaging [12] . While the signal-to-noise ratio increases approximately linearly with field strength, and thus an advantage of imaging at 3T, the energy deposition will increase also, as the square of field strengths. Specific absorption ratio (SAR) limits are likely to be reached more often, typically restricting acquisition parameters, e.g. lengthening the acquisition time.
Standing wave effects are also relevant at 3T. Hz to 440 Hz at 3T. This is relevant to gastrointestinal imaging due to the fat/water interface at the bowel wall, which may lead to chemical misregistration artefacts. This has to be considered when assessing tumor stage (T stage).
Finally, magnetic susceptibility effects also increase linearly with field strength and is two times greater at 3T compared to 1.5T for the same volume. Microscopic gradient differences at the interfaces of materials of different magnetic susceptibility, e.g. air/soft tissue and metal/soft tissue are accentuated at 3T and challenging for gastrointestinal cancers, where luminal gas often lies in proximity of the tumor. MRI acquisition optimization is necessary to mitigate these effects, for example by increasing receiver bandwidth, using spin echo over gradient echo sequences or less B0-sensitive fat suppression techniques.
Imaging Workflow for Gastrointestinal Cancers
Patient preparation for PET/MRI has to consider the requirements of both modalities. For 18 F-FDG PET, pregnancy is a contraindication. A 4-6 hour fast, control of the blood glucose level (<120mg/dL) and minimization of patient movement after FDG injection is also necessary to minimize skeletal muscle uptake. Consideration also has to be made for diabetic patients on metformin. Metformin is known to increase bowel activity diffusely and has been shown to be associated with false negative cancer detection [13] ; replacement of metformin with alternative therapies may be required if this is considerable. The risks for MRI are related to its strong static magnetic field, pulsed magnetic field and radiofrequency field. MRI cardiac pacemakers are an absolute contraindication due to possible device malfunction, localized heating and possible arrhythmias. At 3T some metal implants are also contraindicated due to possible movement and localized heating effects.
For 18 F-FDG, a dose of 2.5-5 MBq/kg is typically injected (up to maximum dose of 740 MBq) [14] and, following a 60-to 90-minute uptake period, the PET/MRI acquisition commenced.
A typical half-body simultaneous hybrid PET/MRI acquisition is shown in Figure 1 . Patient positioning to optimize the MRI signal and to minimize artefacts related to B0
inhomogeneities requires the patient to be centered within the magnetic field and for the surface coils to be positioned appropriately. This can potentially add to technologists' radiation exposure compared to PET/CT, and has to be considered when training technologists.
MR attenuation correction is performed using a 2-point Dixon 3D volume interpolated number of multi-planar sequences [16] .
A possible approach is to read the whole body images, which provide an overview of both the PET molecular and MRI anatomical information as a fused set, and then the locoregional images, which are typically of higher spatial resolution for MRI and acquired in the appropriate planes for gastrointestinal cancers, e.g. parallel and perpendicular to the bowel lumen.
PET/MRI assessment of gastrointestinal cancers
Staging and restaging
Due to its high contrast and spatial resolution, and its ability to depict the relationship of the primary tumor to the potential resection margin, MRI is the standard of care for TNM (tumor-node-metastasis) staging of rectal cancer [17, 18] . Further staging improvement may be gained in terms of nodal and distant metastatic disease by combining PET and MRI information. Similarly, assessment of pelvic recurrent disease may also be improved by combining PET and MRI (Figure 3 ). This is supported by a recent small study which For resectable esophageal cancer, an imaging approach combining endoscopic ultrasound (EUS) with contrast enhanced CT and FDG PET/CT is currently the standard of care.
However, MRI has been shown to be capable of high resolution imaging of the esophagus and the surgical anatomy, particularly with respect to T stage [22, 23] , and potentially allows patient imaging to be more streamlined. To date a small study has compared EUS, CT, 
Therapy response assessment
Another promising area for PET/MRI is therapy response assessment, as a multi-parametric approach is possible providing comprehensive information beyond size change. 
